NRX Pharmaceuticals (NRXP) Goodwill (2025 - 2026)

NRX Pharmaceuticals (NRXP) posted quarterly Goodwill of $1.8 million for Q1 2026, little changed quarter-over-quarter from $1.8 million in Q4 2025.

NRX Pharmaceuticals (NRXP) Goodwill (2025 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has reported Goodwill for 2 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.

In Q1 2026, Goodwill changed N/A year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
Goodwill held at $1.8 million in Q1 2026 per NRXP's latest filing, from $1.8 million in the prior quarter.
Across five years, Goodwill topped out at $1.8 million in Q4 2025 and bottomed at $610000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.41 Bn	131.56 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.14 Bn	78.15 Bn	3.93 Bn
3	Argenx Se	65.52 Bn	60.34 Bn	1.37 Bn
4	Moderna	58.21 Bn	53.07 Bn	52.00 Mn
5	BeOne Medicines	42.15 Bn	37.05 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn
7	BioNTech SE	27.95 Bn	9.56 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.30 Bn	26.46 Bn	-
10	NRX Pharmaceuticals	132.90 Mn	106.20 Mn	426,000.00

Download Data